Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Newell

Showing results (351-360 of 519) with videos related to

Pageof 52
Sort By:
Oncotarget|April 7, 2015
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastomaLindi Chen, Raphaël F Rousseau, Steven A Middleton, et al.
BMJ Open|January 19, 2023
Nudge interventions to reduce unnecessary antibiotic prescribing in primary care: a systematic reviewMagdalena Z Raban, Gabriela Gonzalez, Amy D Nguyen, et al.
British Journal of Cancer|August 19, 2024
Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cellsN Johnson, J Bentley, L-Z Wang, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS)E M Hersh, J M Reuben, P W Mansell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levelsS Ghazal-Aswad, M J Tilby, M Lind, et al.
Diagnostic Immunology|January 1, 1983
Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignanciesE M Hersh, P W Mansell, J M Reuben, et al.
Plos One|May 3, 2013
Priming intelligent behavior: an elusive phenomenonDavid R Shanks, Ben R Newell, Eun Hee Lee, et al.
British Journal of Cancer|December 17, 2009
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cellsN Johnson, J Bentley, L-Z Wang, et al.
Anticancer Research|November 1, 1994
The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a reviewP Bin, A V Boddy, M W English, et al.
The Plant Cell|October 1, 2013
Establishing a framework for the Ad/abaxial regulatory network of Arabidopsis: ascertaining targets of class III homeodomain leucine zipper and KANADI regulationBrenda J Reinhart, Tie Liu, Nicole R Newell, et al.
Pageof 52

Showing results (351-360 of 519) with videos related to

Sort By:
Pageof 52
Oncotarget|April 7, 2015
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastomaLindi Chen, Raphaël F Rousseau, Steven A Middleton, et al.
BMJ Open|January 19, 2023
Nudge interventions to reduce unnecessary antibiotic prescribing in primary care: a systematic reviewMagdalena Z Raban, Gabriela Gonzalez, Amy D Nguyen, et al.
British Journal of Cancer|August 19, 2024
Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cellsN Johnson, J Bentley, L-Z Wang, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Immunological studies of male homosexuals with the prodrome of the acquired immunodeficiency syndrome (AIDS)E M Hersh, J M Reuben, P W Mansell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levelsS Ghazal-Aswad, M J Tilby, M Lind, et al.
Diagnostic Immunology|January 1, 1983
Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignanciesE M Hersh, P W Mansell, J M Reuben, et al.
Plos One|May 3, 2013
Priming intelligent behavior: an elusive phenomenonDavid R Shanks, Ben R Newell, Eun Hee Lee, et al.
British Journal of Cancer|December 17, 2009
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cellsN Johnson, J Bentley, L-Z Wang, et al.
Anticancer Research|November 1, 1994
The comparative pharmacokinetics and pharmacodynamics of cisplatin and carboplatin in paediatric patients: a reviewP Bin, A V Boddy, M W English, et al.
The Plant Cell|October 1, 2013
Establishing a framework for the Ad/abaxial regulatory network of Arabidopsis: ascertaining targets of class III homeodomain leucine zipper and KANADI regulationBrenda J Reinhart, Tie Liu, Nicole R Newell, et al.
Pageof 52